...
首页> 外文期刊>Oncology reports >Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1
【24h】

Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1

机译:通过下调BRPK / PINK1,使人膀胱癌细胞对携带REIC / Dkk-3的基因治疗腺病毒部分致敏

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract. REIC/Dkk-3 is a tumor suppressor gene that was first identified as a gene downregulated in association with immortalization of normal human fibroblasts. We have demonstrated that an adenovirus carrying REIC/Dkk-3 (Ad-REIC) showed a tumor-specific killing effect on a wide range of cancers. However, some human cancers, bladder cancers in particular, are resistant to Ad-REIC. In this study, we investigated the combination effect of downregulation of BRPK/PINK1 (PINK1) and Ad-REIC on bladder cancer cells. Five bladder cancer cell lines among six cell lines examined were resistant to Ad-REIC. Among the cell lines, the resistance of two cell lines was probably due to low infection efficiency of the adenovirus. PINK1-specific siRNA remarkably downregulated Bcl-x L and TRAP1 proteins and upregulated BAX protein expression. Finally, downregulation of PINK1 partially sensitized the other three cell lines that were resistant to Ad-REIC. This sensitization was associated with increasing production of reactive oxygen species (ROS). These results indicate that PINK1 is one of the key molecules for the mitochondrial protection system and that PINK1 can be a new target molecule to sensitize bladder cancer cells that are resistant to Ad-REIC.
机译:抽象。 REIC / Dkk-3是一种肿瘤抑制基因,最初被确定为与正常人成纤维细胞永生化相关的下调基因。我们已经证明携带REIC / Dkk-3(Ad-REIC)的腺病毒对多种癌症表现出特定的杀伤作用。但是,某些人类癌症,尤其是膀胱癌,对Ad-REIC耐药。在这项研究中,我们研究了BRPK / PINK1(PINK1)和Ad-REIC下调对膀胱癌细胞的联合作用。在所检查的六个细胞系中,五个膀胱癌细胞系对Ad-REIC有抗性。在细胞系中,两种细胞系的抗性可能是由于腺病毒的感染效率低。 PINK1特异性siRNA显着下调Bcl-x L和TRAP1蛋白,并上调BAX蛋白表达。最后,PINK1的下调部分使对Ad-REIC有抗性的其他三种细胞株敏感。这种敏化与增加活性氧(ROS)的产生有关。这些结果表明,PINK1是线粒体保护系统的关键分子之一,并且PINK1可以成为敏化对Ad-REIC耐药的膀胱癌细胞的新靶标分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号